Subclinical Infections in Mice Resulting from the Modulation of a Lethal Dose of Semliki Forest Virus with Defective Interfering Viruses: Neurochemical Abnormalities in the Central Nervous System
The lethal encephalitis caused in mice by Semliki Forest virus (SFV) is modulated to a subclinical infection by administration of defective interfering SFV, although virus still multiplies both in the central nervous system (CNS) and systemically. Here we report that such infections result in unique and selective changes in the normal levels of CNS neurotransmitters some of which persist after infectious virus can no longer be detected. This represents a previously undocumented category of infection which may have a bearing on the aetiology of those human neurological and neuropsychiatric diseases to which viruses are believed to contribute.
AtkinsonT., BarrettA. D. T., MackenzieA., DimmockN. J.1986; Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles. Journal of General Virology 67:1189–1194
BarrettA. D. T., DimmockN. J.1984a; Variation of homotypic and heterotypic interference by defective interfering viruses derived from different strains of Semliki Forest virus and from Sindbis virus. Journal of General Virology 65:1119–1122
BarrettA. D. T., DimmockN. J.1984b; Modulation of Semliki Forest virus-induced infection of mice by defective interfering virus. Journal of Infectious Diseases 150:98–104
BarrettA. D. T., DimmockN. J.1984c; Properties of host and virus which influence defective interfering virus-mediated protection of mice against Semliki Forest virus lethal encephalitis. Archives of Virology 81:185–188
BarrettA. D. T., DimmockN. J.1984d; Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus. Journal of General Virology 65:1827–1831
BarrettA. D. T., DimmockN. J.1986; Defective interfering viruses and infections of animals. Current Topics in Microbiology and Immunology 128: (in press)
BarrettA. D. T., CrouchC. F., DimmockN. J.1984a; Defective interfering Semliki Forest virus populations are biologically and physically heterogeneous. Journal of General Virology 65:1273–1283
BarrettA. D. T., GuestA. R., MackenzieA., DimmockN. J.1984b; Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication. Journal of General Virology 65:1909–1920
BradishC. J., AllnerK., MaberH. B.1971; The virulence of original and derived strains of Semliki Forest virus for mice, guinea pigs and rabbits. Journal of General Virology 12:141–160
CrossA. J., JosephM. H.1981; The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection. Life Sciences 28:499–505
CrossA. J., CrowT. J., JohnsonJ. A., NeeleyN. P., TaylorG. R.1984; Effects of experimental herpes simplex virus (HSV) encephalitis on monoamine systems in mouse brain. Journal of Physiology 350:30P
CrouchC. F., MackenzieA., DimmockN. J.1982; The effect of defective interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice. Journal of Infectious Diseases 146:411–416
DimmockN. J., KennedyS. I. T.1978; Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus. Journal of General Virology 39:231–242
FonnumF.1969; Radiochemical microassay for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochemical Journal 115:465–472
FultzP. N., ShadduckJ. A., KangC-Y., StreileinJ. W.1982; Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon. Infection and Immunity 37:679–686
HollandJ. J., DoyleM.1973; Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus. Infection and Immunity 7:526–531
JonesC., HollandJ. J.1980; Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo. Journal of General Virology 49:215–220
LyckeE., ModishK., RoosB. E.1970; The monoamine metabolism in viral encephalitides of the mouse. I. Virological and biochemical results. Brain Research 23:235–246
OldstoneM. B. A., HolmstoenJ., WelshR. M.1977; Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. Journal of Cellular Physiology 91:459–472
OldstoneM. B. A., SinhaY. N., BlountP., TishonA., RodriguezM., Von WedelR., LampertP. W.1982; Virus-induced alterations in homeostasis: alterations in differential functions of infected cells in vivo. Science 218:1125–1127
OldstoneM. B. A., RodriguezM., DaughadeyW. H., LampertP. W.1984a; Viral perturbation of endocrine function: disordered cell function leads to disturbed homeostasis and disease. Nature, London 307:278–280
OldstoneM. B. A., SouthernP., RodriguezM., LampertP.1984b; Virus persists in cells of islets of Langerhans and is associated with chemical manifestations of diabetes. Science 224:1440–1443
SouthernP. J., BlountP., OldstoneM. B. A.1984; Analysis of persistent virus infections by in situ hybridization to whole-mouse sections. Nature, London 312:555–558
SucklingA. J., PathakS., JagelmanS., WebbH. E.1978; Virus-associated demyelination. A model using avirulent Semliki Forest virus infection of mice. Journal of the Neurological Sciences 39:147–154
WaddingtonJ. L., CrossA. J.1978; Neurochemical changes following kainic acid lesions of the nucleus accumbens: implications for a GABAergic accumbal-ventral tegmental pathway. Life Sciences 22:1101–1104
WelshR. M., LampertP. W., OldstoneM. B. A.1977; Prevention of virus-induced cerebellar disease by defective interfering lymphocytic choriomeningitis virus. Journal of Infectious Diseases136391–399
Subclinical Infections in Mice Resulting from the Modulation of a Lethal Dose of Semliki Forest Virus with Defective Interfering Viruses: Neurochemical Abnormalities in the Central Nervous System